1-(carboxymethylthio)tetradecane has been researched along with Heart Failure in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aukrust, P; Beitnes, JO; Berge, RK; Bohov, P; Dahl, CP; Edvardsen, T; Ueland, T; Yndestad, A; Øie, E | 1 |
1 other study(ies) available for 1-(carboxymethylthio)tetradecane and Heart Failure
Article | Year |
---|---|
Tetradecylthioacetic acid increases fat metabolism and improves cardiac function in experimental heart failure.
Topics: Animals; Antioxidants; Fats; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Heart; Heart Failure; Hemodynamics; Lipid Metabolism; Lipids; Male; Myocardial Infarction; Myocardium; Oxidation-Reduction; Rats; Rats, Wistar; Sulfides | 2013 |